Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$235K Sell
178
-286
-62% -$392K 0.03% 136
2025
Q4
$496K Buy
464
+20
+5% +$20.9K 0.1% 103
2025
Q3
$430K Sell
444
-63
-12% -$49.5K 0.06% 112
2025
Q2
$406K Sell
507
-24
-5% -$17.2K 0.11% 119
2025
Q1
$352K Buy
+531
New +$386K 0.09% 141
2023
Q4
Sell
-2,693
Closed -$1.59M 228
2023
Q3
$1.59M Buy
+2,693
New +$1.79M 0.35% 48
2019
Q2
Sell
-5,363
Closed -$1.01M 117
2019
Q1
$1.01M Sell
5,363
-13,942
-72% -$2.47M 0.08% 69
2018
Q4
$3M Buy
+19,305
New +$3.27M 0.26% 35

Other funds holding ASML

Wexford Capital's ASML Position: Q1 2026 in Review

Wexford Capital reduced its ASML (ASML) stake by 62% in Q1 2026, selling an estimated $392K and leaving 178 shares worth $235K. The position accounts for 0.03% of the portfolio, ranked #136.

Wexford Capital first reported a position in ASML in Q4 2018 and has held it in 8 quarters since. The position peaked at $3M in Q4 2018. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

  • Wexford Capital held 178 shares of ASML worth $235K as of Q1 2026.
  • Wexford Capital sold 286 ASML shares in Q1 2026, an estimated $392K.
  • ASML made up 0.03% of Wexford Capital's portfolio in Q1 2026, its #136 holding.
  • Wexford Capital first reported a position in ASML in Q4 2018 and has held it in 8 quarters since.
  • Wexford Capital's ASML position peaked at $3M in Q4 2018.
  • 2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Wexford Capital's 13F filing for Q1 2026, filed 15 May 2026.